|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1998-11-9
|
|
pubmed:abstractText |
In an effort to augment the anti-Helicobacter pylori effect of amoxicillin, mucoadhesive microspheres, which have the ability to reside in the gastrointestinal tract for an extended period, were prepared. The microspheres contained the antimicrobial agent and an adhesive polymer (carboxyvinyl polymer) powder dispersed in waxy hydrogenated castor oil. The percentage of amoxicillin remaining in the stomach both 2 and 4 h after oral administration of the mucoadhesive microspheres to Mongolian gerbils under fed conditions was about three times higher than that after administration in the form of a 0.5% methylcellulose suspension. The in vivo clearance of H. pylori following oral administration of the mucoadhesive microspheres and the 0.5% methylcellulose suspension to infected Mongolian gerbils was examined under fed conditions. The mucoadhesive microspheres and the 0.5% methylcellulose suspension both showed anti-H. pylori effects in this experimental model of infection, but the required dose of amoxicillin was effectively reduced by a factor of 10 when the mucoadhesive microspheres were used. In conclusion, the mucoadhesive microspheres more effectively cleared H. pylori from the gastrointestinal tract than the 0.5% methylcellulose suspension due to the prolonged gastrointestinal residence time resulting from mucoadhesion. A dosage form consisting of mucoadhesive microspheres containing an appropriate antimicrobial agent should be useful for the eradication of H. pylori.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/9756746-1449132,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9756746-1486161,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9756746-1912414,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9756746-1971318,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9756746-2252013,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9756746-2327758,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9756746-2935076,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9756746-3335295,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9756746-3700291,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9756746-7617528,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9756746-7729633,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9756746-7801950,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9756746-7986961,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9756746-8007082,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9756746-8363383,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9756746-8419816,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9756746-8561152,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9756746-8561153,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9756746-8937967,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9756746-9530983
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0066-4804
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
42
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2492-4
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Mucoadhesive microspheres containing amoxicillin for clearance of Helicobacter pylori.
|
|
pubmed:affiliation |
DDS Research Laboratories, Pharmaceutical Research Division, Takeda Chemical Industries, Ltd., Osaka, Japan. Nagahara_Naoki@Takeda.co.jp
|
|
pubmed:publicationType |
Journal Article
|
